Therapeutic short hairpin RNA expression in the liver: viral targets and vectors - PubMed (original) (raw)

Review

Therapeutic short hairpin RNA expression in the liver: viral targets and vectors

D Grimm et al. Gene Ther. 2006 Mar.

Abstract

Over 500 million people worldwide are infected with one or more different and unrelated types of human hepatitis virus. Such individuals are at a high risk of developing acute or chronic hepatic disease, and ultimately dying from sequelae. Although a vaccine is available for hepatitis A and B virus, treatment options for chronically infected patients are limited, and particularly ineffective in case of hepatitis C virus (HCV) infection. A promising new avenue currently being explored is to harness the power of RNA interference for development of an antiviral therapy. The timing to pursue this particular approach is excellent, with the first in vivo animal models for HCV infection becoming available, and the technology for liver-specific expression of short hairpin RNAs advancing at a rapid pace. Here, we critically review these important current developments, and discuss the next steps to bring this novel approach into the clinics.

Gene Therapy (2006) 13, 563-575. doi:10.1038/sj.gt.3302727; published online 2 February 2006.

PubMed Disclaimer

Similar articles

• Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.
  Rauschhuber C, Xu H, Salazar FH, Marion PL, Ehrhardt A. Rauschhuber C, et al. J Gene Med. 2008 Aug;10(8):878-89. doi: 10.1002/jgm.1207. J Gene Med. 2008. PMID: 18470951
• Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.
  Arbuthnot P, Longshaw V, Naidoo T, Weinberg MS. Arbuthnot P, et al. J Viral Hepat. 2007 Jul;14(7):447-59. doi: 10.1111/j.1365-2893.2006.00818.x. J Viral Hepat. 2007. PMID: 17576386 Review.
• Potential applications of siRNA in hepatitis C virus therapy.
  Smolic R, Volarevic M, Wu CH, Wu GY. Smolic R, et al. Curr Opin Investig Drugs. 2006 Feb;7(2):142-6. Curr Opin Investig Drugs. 2006. PMID: 16499284 Review.
• Therapeutic application of RNA interference for hepatitis C virus.
  Watanabe T, Umehara T, Kohara M. Watanabe T, et al. Adv Drug Deliv Rev. 2007 Oct 10;59(12):1263-76. doi: 10.1016/j.addr.2007.03.022. Epub 2007 Aug 11. Adv Drug Deliv Rev. 2007. PMID: 17822803 Review.
• Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model.
  Wang Q, Contag CH, Ilves H, Johnston BH, Kaspar RL. Wang Q, et al. Mol Ther. 2005 Sep;12(3):562-8. doi: 10.1016/j.ymthe.2005.04.014. Mol Ther. 2005. PMID: 15953767

Cited by

• Decompartmentalizing target validation-thinking outside the pipeline boxes.
  Hooft van Huijsduijnen R, Rommel C. Hooft van Huijsduijnen R, et al. J Mol Med (Berl). 2006 Oct;84(10):802-13. doi: 10.1007/s00109-006-0080-2. Epub 2006 Aug 5. J Mol Med (Berl). 2006. PMID: 16924470 Review. No abstract available.
• Constitutive expression of short hairpin RNA in vivo triggers buildup of mature hairpin molecules.
  Ahn M, Witting SR, Ruiz R, Saxena R, Morral N. Ahn M, et al. Hum Gene Ther. 2011 Dec;22(12):1483-97. doi: 10.1089/hum.2010.234. Epub 2011 Oct 4. Hum Gene Ther. 2011. PMID: 21780944 Free PMC article.
• Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs.
  Theotokis PI, Usher L, Kortschak CK, Schwalbe E, Moschos SA. Theotokis PI, et al. Mol Ther Nucleic Acids. 2017 Dec 15;9:22-33. doi: 10.1016/j.omtn.2017.08.010. Epub 2017 Aug 24. Mol Ther Nucleic Acids. 2017. PMID: 29246301 Free PMC article.
• Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
  Grimm D, Kay MA. Grimm D, et al. J Clin Invest. 2007 Dec;117(12):3633-41. doi: 10.1172/JCI34129. J Clin Invest. 2007. PMID: 18060021 Free PMC article. Review.
• The potential of RNA interference-based therapies for viral infections.
  Huang DD. Huang DD. Curr HIV/AIDS Rep. 2008 Feb;5(1):33-9. doi: 10.1007/s11904-008-0006-4. Curr HIV/AIDS Rep. 2008. PMID: 18417033 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information